N6-Alkyladenosines: Synthesis and evaluation of in vitro anticancer activity

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 23, 2010, Pages 8396-8402

  Ottria, Roberta ^a   Casati, Silvana ^a   Baldoli, Erika ^a   Maier, Jeanette A M ^a   Ciuffreda, Pierangela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antitumor agents; Bladder carcinoma cells; Cytokinins; Isopentenyladenosine; Modified nucleosides

Indexed keywords

6 N (3,3 DIMETHYLALLYL)ADENOSINE; 6 N BENZYLADENOSINE; 6 N ISOPROPYLADENOSINE; ADENOSINE DERIVATIVE; ANTINEOPLASTIC AGENT; METALLOPROTEINASE; N 6 (3 HYDROXY 2 METHYLPROPYL) ADENOSINE; N 6 2 PHENYLETHYLADENOSINE; N 6 2,3 DIHYDROXY PROPYLADENOSINE; N 6 3' (DIMETHYLAMINO)PROPYLADENOSINE; N 6 ALLYLADENOSINE; N 6 BUTYLADENOSINE; N 6 CYCLOBUTYLMETHYLADENOSINE; N 6 CYCLOHEXYLADENOSINE; N 6 CYCLOPENTYLADENOSINE; N 6 CYCLOPROPYLMETHYLADENOSINE; N 6 ISOBUTYLADENOSINE; UNCLASSIFIED DRUG; ADENOSINE; CYTOKININ; DRUG DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BLADDER CANCER; BREAST CARCINOMA; CANCER CELL; CELL INVASION; CELL PROLIFERATION; COLON CARCINOMA; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; IN VITRO STUDY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTITUTION REACTION; BLADDER TUMOR; CHEMISTRY; HUMAN; METABOLISM; SYNTHESIS; TUMOR CELL LINE;

ADENOSINE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYTOKININS; HUMANS; METALLOPROTEASES; URINARY BLADDER NEOPLASMS;

EID: 78249284955     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.09.030     Document Type: Article

References (25)

1. F. Skoog, and D.J. Armstrong Annu. Rev. Plant Physiol. 21 1970 359
2. M.C. Mok Cytokinins and Plant Development-an Overview D.W.S. Mok, M.C. Mok, Cytokinins: Chemistry, Activity and Function 1994 CRC Press Boca Raton FL 155
3. S. Tanimoto, and H. Harada Plant Cell Physiol. 23 1982 1371
4. J.R. Faust, and J.F. Dice J. Biol. Chem. 266 1991 9961
5. M. Spinola, F. Colombo, F.S. Falvella, and T.A. Dragani Int. J. Cancer 120 2007 2744
6. A. Mittelman, J.T. Evans, and G.B. Chheda Ann. N.Y. Acad. Sci. 34 1975 255
7. G.B. Chheda, and A. Mittelman Biochem. Pharmacol. 21 1972 27
8. R. Ottria, S. Casati, J.A.M. Maier, M. Mariotti, and P. Ciuffreda Nucleosides Nucleotides Nucleic Acids 28 2009 736
9. R. Ottria, S. Casati, A. Manzocchi, E. Baldoli, M. Mariotti, J.A.M. Maier, and P. Ciuffreda Bioorg. Med. Chem. 18 2010 4249
10. M.A. Knowles Carcinogenesis 27 2006 361
11. M.H. Fleysher, M.T. Hakala, A. Bloch, and R.H. Hall J. Med. Chem. 11 1968 717
12. M.H. Fleysher J. Med. Chem. 15 1972 187
13. N.J. Leonard, S. Achmatowicz, R.N. Loeppky, K.L. Carraway, W.A.H. Grimm, A. Szweykowska, Q.H. Hamzi, and F. Skoog Proc. Natl. Acad. Sci. U.S.A. 56 1966 709
14. M.J. Robins, and E.M. Trip Biochemistry 12 1973 2179
15. A. Albini Pathol. Oncol. Res. 4 1998 230
16. K. Kessenbrock, V. Plaks, and Z. Werb Cell 141 2010 52
17. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. Thun Cancer J. Clin. 59 2009 225
18. B. Ewald, D. Sampath, and W. Plunkett Oncogene 27 2008 6522
19. N.J. Leonard, S.M. Hecht, F. Skoog, and R.Y. Schimdts Proc. Natl. Acad. Sci. U.S.A. 59 1968 15
20. M.H. Fleysher, R.J. Bernacki, and G.A. Bullard J. Med. Chem. 23 1980 1448
21. O. Zemlicka J. Org. Chem. 42 1977 517
22. S. Vittori, A. Lorenzen, C. Stannek, S. Costanzi, R. Volpini, A.P. IJzerman, J.K. von Frijtag Drabbe Künzel, and G. Cristalli J. Med. Chem. 43 2000 250
23. E.W. van Tilburg, J. von Frijtag Drabbe Künzel, M. de Groote, R.C. Vollinga, A. Lorenzen, and A.P. IJzerman J. Med. Chem. 42 1999 1393
24. N. Shimazaki, I. Shima, K. Hemmi, and M. Hashimoto J. Med. Chem. 30 1987 1709
25. Y. Li, K. Yang, Q. Mao, X. Zheng, D. Kong, and L. Xie Int. Urol. Nephrol. 2009 10.1007/s11255-009-9620-3